Logo image of NILE

BITNILE HOLDINGS INC (NILE) Stock Fundamental Analysis

NYSEARCA:NILE - NYSE Arca - US09175M1018 - Common Stock - Currency: USD

0.1225  +0.02 (+22.5%)

After market: 0.127 +0 (+3.67%)

Fundamental Rating

2

Taking everything into account, NILE scores 2 out of 10 in our fundamental rating. NILE was compared to 94 industry peers in the Electrical Equipment industry. Both the profitability and financial health of NILE have multiple concerns. NILE shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NILE has reported negative net income.
In the past year NILE had a positive cash flow from operations.
NILE Yearly Net Income VS EBIT VS OCF VS FCFNILE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -50M -100M -150M -200M

1.2 Ratios

NILE has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NILE Yearly ROA, ROE, ROICNILE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 -100 -200 -300 -400

1.3 Margins

NILE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NILE Yearly Profit, Operating, Gross MarginsNILE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 50 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

NILE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NILE has more shares outstanding
The debt/assets ratio for NILE is higher compared to a year ago.
NILE Yearly Shares OutstandingNILE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
NILE Yearly Total Debt VS Total AssetsNILE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -0.37, we must say that NILE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.37, NILE is doing worse than 77.65% of the companies in the same industry.
A Debt/Equity ratio of 0.23 indicates that NILE is not too dependend on debt financing.
NILE has a Debt to Equity ratio (0.23) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z -0.37
ROIC/WACCN/A
WACC7.39%
NILE Yearly LT Debt VS Equity VS FCFNILE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 100M -100M 200M -200M

2.3 Liquidity

NILE has a Current Ratio of 1.34. This is a normal value and indicates that NILE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.34, NILE is doing worse than 82.35% of the companies in the same industry.
A Quick Ratio of 0.96 indicates that NILE may have some problems paying its short term obligations.
The Quick ratio of NILE (0.96) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 0.96
NILE Yearly Current Assets VS Current LiabilitesNILE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for NILE have decreased strongly by -168.18% in the last year.
The Revenue has grown by 108.21% in the past year. This is a very strong growth!
The Revenue has been growing by 47.15% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-168.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.6%
Revenue 1Y (TTM)108.21%
Revenue growth 3Y24.5%
Revenue growth 5Y47.15%
Sales Q2Q%261.65%

3.2 Future

Based on estimates for the next years, NILE will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.92% on average per year.
NILE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 58.52% yearly.
EPS Next Y-233.33%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5Y18.92%
Revenue Next Year120.27%
Revenue Next 2Y75.79%
Revenue Next 3Y69.31%
Revenue Next 5Y58.52%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NILE Yearly Revenue VS EstimatesNILE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
NILE Yearly EPS VS EstimatesNILE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 -0.05 -0.1 -0.15 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NILE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NILE Price Earnings VS Forward Price EarningsNILE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NILE Per share dataNILE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A more expensive valuation may be justified as NILE's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NILE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BITNILE HOLDINGS INC

NYSEARCA:NILE (12/30/2022, 8:04:02 PM)

After market: 0.127 +0 (+3.67%)

0.1225

+0.02 (+22.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-21 2022-11-21/amc
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner Change0%
Ins Owners0.04%
Ins Owner Change0%
Market Cap41.83M
Analysts82.5
Price Target3.83 (3026.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-0.28%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-684.31%
Min EPS beat(2)-684.31%
Max EPS beat(2)-684.31%
EPS beat(4)1
Avg EPS beat(4)-378.46%
Min EPS beat(4)-684.31%
Max EPS beat(4)69.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)33.52%
Min Revenue beat(2)-38.86%
Max Revenue beat(2)105.9%
Revenue beat(4)3
Avg Revenue beat(4)53.34%
Min Revenue beat(4)-38.86%
Max Revenue beat(4)118.36%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.39
P/FCF N/A
P/OCF 5.12
P/B 0.13
P/tB 0.17
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)0.02
OCFY19.55%
SpS0.32
BVpS0.94
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1549.29%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 0.96
Altman-Z -0.37
F-Score2
WACC7.39%
ROIC/WACCN/A
Cap/Depr(3y)2073.29%
Cap/Depr(5y)1340.89%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-168.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.6%
EPS Next Y-233.33%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5Y18.92%
Revenue 1Y (TTM)108.21%
Revenue growth 3Y24.5%
Revenue growth 5Y47.15%
Sales Q2Q%261.65%
Revenue Next Year120.27%
Revenue Next 2Y75.79%
Revenue Next 3Y69.31%
Revenue Next 5Y58.52%
EBIT growth 1Y-971.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year82.19%
EBIT Next 3Y90.99%
EBIT Next 5Y94.86%
FCF growth 1Y-1716.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-451.57%
OCF growth 3YN/A
OCF growth 5YN/A